Pain in chemotherapy-induced peripheral neurotoxicity.

about

Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.

P2860

Q52693014-B9673073-31F1-4BDB-B62E-E76E90AFA61C

P2860

Pain in chemotherapy-induced peripheral neurotoxicity.

Item

http://www.wikidata.org/entity/Q39363713

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pain in chemotherapy-induced peripheral neurotoxicity.

@en

Pain in chemotherapy-induced peripheral neurotoxicity.

@nl

type

Item

label

Pain in chemotherapy-induced peripheral neurotoxicity.

@en

Pain in chemotherapy-induced peripheral neurotoxicity.

@nl

prefLabel

Pain in chemotherapy-induced peripheral neurotoxicity.

@en

Pain in chemotherapy-induced peripheral neurotoxicity.

@nl

P1476

Pain in chemotherapy-induced peripheral neurotoxicity.

@en

P2093

Arianna Scuteri

http://www.w3.org/2001/XMLSchema#string

David R Cornblath

http://www.w3.org/2001/XMLSchema#string

Paola Marmiroli

http://www.w3.org/2001/XMLSchema#string

P2860

Mitotoxicity in distal symmetrical sensory peripheral neuropathies

Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.

Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain.

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.

P304

156-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JNS.12226

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guido Cavaletti

P577

2017-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28600844

http://www.w3.org/2001/XMLSchema#string

P921

neurotoxicity

Pain in chemotherapy-induced peripheral neurotoxicity.

about

P2860

P2860

Pain in chemotherapy-induced peripheral neurotoxicity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921